Results from previous studies on polyunsaturated fatty acid (PUFA) intake and multiple sclerosis (MS) risk are conflicting.
Objective:
To prospectively investigate the association between dietary intake of PUFA and MS risk.
Methods:
We followed 80,920 women from Nurses’ Health Study (1984–2004) and 94,511 women from Nurses’ Health Study II (1991–2009) who reported on diet using a validated food frequency questionnaire every 4 years and identified 479 incident MS cases during follow-up. We used Cox regression to estimate hazard ratios (HRs) and 95% confidence intervals (CIs), for the effect of PUFA intake on MS risk adjusting for age, latitude of residence at age 15, ancestry, cigarette smoking, supplemental vitamin D intake, body mass index, and total energy intake.
Results:
Higher intake of total PUFA at baseline was associated with a lower risk of MS (HR top vs bottom quintile: 0.67, 95% CI: 0.49–0.90, p trend = 0.01). Among the specific types of PUFA, only α-linolenic acid (ALA) was inversely associated with MS risk (HR top vs bottom quintile: 0.61, 95% CI: 0.45–0.83, p trend = 0.001). The long-chain fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were not associated with MS risk.
Conclusion:
Low dietary PUFA intake may be another modifiable risk factor for MS.
SwankRL. Multiple sclerosis: A correlation of its incidence with dietary fat. Am J Med Sci1950; 220: 421–430.
2.
SwankRLLerstadOStromAet al. Multiple sclerosis in rural Norway its geographic and occupational incidence in relation to nutrition. N Engl J Med1952; 246: 722–728.
3.
ThompsonRH. A biochemical approach to the problem of multiple sclerosis. Proc R Soc Med1966; 59: 269–276.
4.
BaarnhielmMOlssonTAlfredssonL. Fatty fish intake is associated with decreased occurrence of multiple sclerosis. Mult Scler2014; 20: 726–732.
5.
KampmanMTWilsgaardTMellgrenSI. Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. J Neurol2007; 254: 471–477.
6.
GhadirianPJainMDucicSet al. Nutritional factors in the aetiology of multiple sclerosis: A case-control study in Montreal, Canada. Int J Epidemiol1998; 27: 845–852.
7.
CorteseMRiiseTBjornevikKet al. Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study. Mult Scler2015; 21: 1856–1864.
8.
BerrCPuelJClanetMet al. Risk factors in multiple sclerosis: A population-based case-control study in Hautes-Pyrenees, France. Acta Neurol Scand1989; 80: 46–50.
9.
HoareSLithanderFvan der MeiIet al. Higher intake of omega-3 polyunsaturated fatty acids is associated with a decreased risk of a first clinical diagnosis of central nervous system demyelination: Results from the Ausimmune Study. Mult Scler2016; 22: 884–892.
10.
ZhangSMWillettWCHernanMAet al. Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women. Am J Epidemiol2000; 152: 1056–1064.
11.
GiovannucciEStampferMJColditzGAet al. A comparison of prospective and retrospective assessments of diet in the study of breast cancer. Am J Epidemiol1993; 137: 502–511.
12.
RheeJJSampsonLChoEet al. Comparison of methods to account for implausible reporting of energy intake in epidemiologic studies. Am J Epidemiol2015; 181: 225–233.
13.
HernanMAOlekMJAscherioA. Geographic variation of MS incidence in two prospective studies of US women. Neurology1999; 53: 1711–1718.
14.
WillettWCSampsonLBrowneMLet al. The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol1988; 127: 188–199.
15.
SalviniSHunterDJSampsonLet al. Food-based validation of a dietary questionnaire: The effects of week-to-week variation in food consumption. Int J Epidemiol1989; 18: 858–867.
16.
US Department of Agriculture, Agricultural Research Service, Nutrient Data Laboratory. USDA national nutrient database for standard reference (Release 28), https://ndb.nal.usda.gov/ndb/
17.
WillettWC. Nutritional epidemiology. New York: Oxford University Press, 2012.
18.
GarlandMSacksFMColditzGAet al. The relation between dietary intake and adipose tissue composition of selected fatty acids in US women. Am J Clin Nutr1998; 67: 25–30.
19.
HunterDJRimmEBSacksFMet al. Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men. Am J Epidemiol1992; 135: 418–427.
20.
World Health Organization (WHO). Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser2000; 894: i–xii, 1–253.
21.
DurrlemanSSimonR. Flexible regression models with cubic splines. Stat Med1989; 8: 551–561.
22.
DerSimonianRLairdN. Meta-analysis in clinical trials. Control Clin Trials1986; 7: 177–188.
23.
AscherioAMungerKLLunemannJD. The initiation and prevention of multiple sclerosis. Nat Rev Neurol2012; 8: 602–612.
24.
CalderPC. Omega-3 polyunsaturated fatty acids and inflammatory processes: Nutrition or pharmacology?Br J Clin Pharmacol2013; 75: 645–662.
25.
FlemingJAKris-EthertonPM. The evidence for alpha-linolenic acid and cardiovascular disease benefits: Comparisons with eicosapentaenoic acid and docosahexaenoic acid. Adv Nutr2014; 5: 863S–876S.
26.
MichaRKhatibzadehSShiPet al. Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: A systematic analysis including 266 country-specific nutrition surveys. BMJ2014; 348: g2272.
27.
TorkildsenOWergelandSBakkeSet al. ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): A randomized, double-blind, placebo-controlled trial. Arch Neurol2012; 69: 1044–1051.
BurdgeGC. Metabolism of alpha-linolenic acid in humans. Prostaglandins Leukot Essent Fatty Acids2006; 75: 161–168.
30.
LiouYAKingDJZibrikDet al. Decreasing linoleic acid with constant alpha-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men. J Nutr2007; 137: 945–952.
31.
Lopez-GarciaESchulzeMBMansonJEet al. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr2004; 134:1806–1811.
32.
ZhaoGEthertonTDMartinKRet al. Dietary alpha-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects. Am J Clin Nutr2007; 85: 385–391.
33.
RallidisLSPaschosGLiakosGKet al. Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis2003; 167: 237–242.
34.
DewellAMarvastiFFHarrisWSet al. Low- and high-dose plant and marine (n-3) fatty acids do not affect plasma inflammatory markers in adults with metabolic syndrome. J Nutr2011; 141: 2166–2171.
35.
VeldhoenMHockingRJAtkinsCJet al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity2006; 24: 179–189.
36.
BettelliECarrierYGaoWet al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature2006; 441: 235–238.
37.
PoissonLMSuhailHSinghJet al. Untargeted plasma metabolomics identifies endogenous metabolite with drug-like properties in chronic animal model of multiple sclerosis. J Biol Chem2015; 290: 30697–30712.
